A research team from Sage Therapeutics (MA, USA) have completed a preliminary study utilizing a novel drug – SAGE-718 – to treat mild cognitive impairment and dementia associated with Alzheimer’s disease.
Their findings suggest that SAGE-718 is safe and might be associated with improvements in executive function, thinking and memory skills. SAGE-718 is a positive allosteric modulator of N-methyl-D-aspartate receptors.
[ui-btn url=”https://www.neuro-central.com/aan-2022-novel-drug-may-prove-useful-as-a-treatment-for-dementia/” text=”READ MORE ON NEURO CENTRAL NOW” target=”_blank”][/ui-btn]
The post Novel drug may prove useful as a treatment for dementia appeared first on BioTechniques.
Powered by WPeMatico